This is the authors' abstract. We don't add key points for this paper.
The rapid conversion of an MFM platform from convention medical treatment to telemedicine platform in response to the novel coronavirus pandemic resulted in protection of healthcare personnel and MFM patients, with only a modest decrease in clinical productivity during the initial roll-out. Due to the ongoing threat from the novel coronavirus-19, an MFM telemedicine platform is a practicable and innovative solution and merits the continued support of CMS and health care administrators.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Shields et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: